Achieve Names Two New Exemplary Healthcare Leaders to its Board of Directors New Leadership and Financing, up to $354 Million...
$180 Million Financing Upfront with Up to an Additional $174 Million from Warrants Exercisable Within 20 Days of FDA Approval...
Company Offers Comprehensive Child Harm Dataset to Plaintiff Counsel as MDL 3047 School District Trials ApproachREDWOOD CITY, Calif., April 14, 2026...
TORONTO, April 14, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today that Novari Health...
SEATTLE, April 09, 2026 (GLOBE NEWSWIRE) -- This year, SOUND Behavioral Health celebrates a remarkable milestone: 60 years of serving the...
Former Cigna-Evernorth CMO joins advisory board as the company continues to scale its delivery of specialized evidence-based care in the...
Phase 1 clinical trial will evaluate the safety, tolerability, and pharmacokineticsSBS-147 is a novel and potent oral analgesic with a...
New Outsmart Nicotine ads, which also include cigarettes and e-cigarettes, highlight the cycle of stress, cravings and nicotine addiction, and...
Houston Physician Dr. Nathan Starke Launches a Concierge Practice Built Around House Calls, Telemedicine, 24/7 Direct Access for Patients of...
Matthew Mosquera Matthew Mosquera, MD, MS BOSTON, April 07, 2026 (GLOBE NEWSWIRE) -- Lumin Health, a physician-led provider of interventional...
IRVINE, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- GATC Health Corp, a leading tech-bio company leveraging artificial intelligence (AI) to...
Three new license agreements signed and two research shipments completed in March 2026, spanning institutions in Australia, the United Kingdom,...
Northvale, New Jersey--(Newsfile Corp. - April 2, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company...
~ Fourth Quarter Highlighted by Clinical and Regulatory Milestones Positioning PF614 for Late-Stage Advancement ~ SAN DIEGO, CA / ACCESS...
Investment accelerates U.S. rollout of a scalable, at-home brain neuromodulation therapy for patients with depression and inadequate response to at least...
-- Studies highlight reduced total cost of care and select healthcare resource utilization outcomes in total knee arthroplasty (TKA) and...
Vancouver, Canada, March 27, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech...
Preclinical findings show cytisinicline's minimal 5-HT3 serotonin receptor binding offers insight into observed low nausea rates in smoking and vaping...
Preclinical findings show cytisinicline's minimal 5-HT3 serotonin receptor binding offers insight into observed low nausea rates in smoking and vaping...
BURLINGTON, Mass. and JERUSALEM, March 26, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...